Sunitinib carboxylic acid
Sunitinib carboxylic acid is a carboxylic acid metabolite of Sunitinib. Sunitinib is a multi-target tyrosine kinase inhibitor, mainly used to inhibit malignant tumors such as gastrointestinal stromal tumors, renal cell carcinoma, and pancreatic neuroendocrine tumors[1].
Product Specifications
CAS Number
452105-33-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(C1=C(C)NC(/C=C2C(NC3=C\2C=C(F)C=C3)=O)=C1C)O
Molecular Formula
C16H13FN2O3
Molecular Weight
300.28
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362-P405-P501
References & Citations
[1]Sun M, et al. Rapid screening of nine unradiolabeled candidate compounds as PET brain imaging agents using cassette-wave microdosing and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jul 15;1121:28-38.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog